Log in

NYSE:WAT - Waters Stock Price, Forecast & News

$185.36
-6.06 (-3.17 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$181.71
Now: $185.36
$189.23
50-Day Range
$162.36
MA: $199.39
$224.37
52-Week Range
$154.39
Now: $185.36
$255.21
Volume497,425 shs
Average Volume756,876 shs
Market Capitalization$11.52 billion
P/E Ratio21.11
Dividend YieldN/A
Beta1.18
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Read More
Waters logo

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
CUSIP94184810
Phone508-478-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.41 billion
Cash Flow$10.79 per share
Book Value($3.36) per share

Profitability

Net Income$592.20 million

Miscellaneous

Employees7,500
Market Cap$11.52 billion
Next Earnings Date4/28/2020 (Estimated)
OptionableOptionable

Receive WAT News and Ratings via Email

Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.


Waters (NYSE:WAT) Frequently Asked Questions

How has Waters' stock been impacted by COVID-19 (Coronavirus)?

Waters' stock was trading at $184.10 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, WAT shares have increased by 0.7% and is now trading at $185.36. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Waters?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings and 5 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View analyst ratings for Waters.

When is Waters' next earnings date?

Waters is scheduled to release its next quarterly earnings announcement on Tuesday, April 28th 2020. View our earnings forecast for Waters.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) issued its earnings results on Tuesday, February, 4th. The medical instruments supplier reported $3.20 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $3.01 by $0.19. The medical instruments supplier earned $716 million during the quarter, compared to the consensus estimate of $714.34 million. Waters had a net margin of 24.61% and a return on equity of 172.16%. Waters's revenue was up .1% on a year-over-year basis. During the same period last year, the business earned $2.87 earnings per share. View Waters' earnings history.

How will Waters' stock buyback program work?

Waters announced that its board has initiated a stock repurchase plan on Tuesday, April 24th 2018, which authorizes the company to repurchase $3,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 18.2% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's leadership believes its shares are undervalued.

What guidance has Waters issued on next quarter's earnings?

Waters issued an update on its FY20 earnings guidance on Tuesday, February, 4th. The company provided earnings per share guidance of $9.15-$9.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.80.

What price target have analysts set for WAT?

11 analysts have issued 12 month price objectives for Waters' shares. Their forecasts range from $150.00 to $230.00. On average, they expect Waters' share price to reach $194.71 in the next twelve months. This suggests a possible upside of 5.0% from the stock's current price. View analysts' price targets for Waters.

Has Waters been receiving favorable news coverage?

News headlines about WAT stock have been trending positive this week, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Waters earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned media headlines about the medical instruments supplier a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next few days. View the latest news aboutWaters.

Are investors shorting Waters?

Waters saw a drop in short interest during the month of March. As of March 13th, there was short interest totaling 4,335,600 shares, a drop of 7.8% from the February 27th total of 4,700,000 shares. Based on an average trading volume of 514,100 shares, the days-to-cover ratio is currently 8.4 days. Currently, 7.0% of the company's stock are short sold. View Waters' Current Options Chain.

Who are some of Waters' key competitors?

What other stocks do shareholders of Waters own?

Who are Waters' key executives?

Waters' management team includes the following people:
  • Christopher James O'Connell, Chairman & CEO (Age 52)
  • Mr. Christopher James O'Connell, Chairman & CEO (Age 52)
  • Ms. Sherry L. Buck, Sr. VP & CFO (Age 55)
  • Mr. Francis S. Kim, Sr. VP of Global Operations (Age 52)
  • Mr. Robert G. Carson, Sr. VP of Corp. Devel. & Interim Pres of TA Bus. (Age 45)

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Who are Waters' major shareholders?

Waters' stock is owned by a variety of retail and institutional investors. Top institutional investors include Massachusetts Financial Services Co. MA (8.71%), Bank of New York Mellon Corp (7.14%), State Street Corp (4.50%), Baillie Gifford & Co. (3.68%), Janus Henderson Group PLC (2.55%) and Champlain Investment Partners LLC (1.55%). Company insiders that own Waters stock include Christopher A Kuebler, Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View institutional ownership trends for Waters.

Which major investors are selling Waters stock?

WAT stock was sold by a variety of institutional investors in the last quarter, including Fenimore Asset Management Inc., FMR LLC, State Street Corp, Baillie Gifford & Co., Jensen Investment Management Inc., Pictet Asset Management Ltd., Triodos Investment Management BV, and Trillium Asset Management LLC. Company insiders that have sold Waters company stock in the last year include Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, and Mark T Beaudouin. View insider buying and selling activity for Waters.

Which major investors are buying Waters stock?

WAT stock was bought by a variety of institutional investors in the last quarter, including Norges Bank, Anchor Capital Advisors LLC, Amundi Pioneer Asset Management Inc., Man Group plc, Great West Life Assurance Co. Can, Credit Suisse AG, Mawer Investment Management Ltd., and Bank of New York Mellon Corp. View insider buying and selling activity for Waters.

How do I buy shares of Waters?

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $185.36.

How big of a company is Waters?

Waters has a market capitalization of $11.52 billion and generates $2.41 billion in revenue each year. The medical instruments supplier earns $592.20 million in net income (profit) each year or $8.99 on an earnings per share basis. Waters employs 7,500 workers across the globe. View additional information about Waters.

What is Waters' official website?

The official website for Waters is http://www.waters.com/.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]


MarketBeat Community Rating for Waters (NYSE WAT)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  411 (Thanks for Voting!)
Underperform Votes:  569 (Thanks for Voting!)
Total Votes:  980
MarketBeat's community ratings are surveys of what our community members think about Waters and other stocks. Vote "Outperform" if you believe WAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WAT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel